| UNVC Stock | | | USD 0 0.0004 12.50% |
CEO
Dr. David Dalton has served as President and Chief Executive Officer of Univec, Inc. since January 1, 2002, concurrent with the acquisition by Univec, Inc. of Physician and Pharmaceutical Services, Inc., a Baltimore based company founded by Dr. Dalton and the company whollyowned subsidiary. Dr. Dalton was the President of PPSI since 1995. Dr. Dalton has over 35 years experience in the healthcare industry, including 18 years with RiteAid where he served as Corporationrationrate Vice President. Dr. Dalton founded Health Resources, Inc., in 1983, a pharmacy service provider having contracts with over 50, 000 retail pharmacies for billing and payment of prescription orders through plan providers. HRI is recognized as one of the leading Black Enterprises in the United States. Dr. Dalton also founded Pharmacy Services, Inc., a pharmacy fulfillment center for correctional and other institutions, with facilities in Maryland, Tennessee and Pennsylvania since 2002.
| Age | 74 |
| Tenure | 22 years |
| Phone | 410-347-9959 |
| Web | https://www.univec.com |
Dalton graduated from West Virginia University in 1971 with a B.S. in Pharmacy.
Univec Management Efficiency
The company has return on total asset
(ROA) of
(0.4376) % which means that it has lost $0.4376 on every $100 spent on assets. This is way below average. Univec's management efficiency ratios could be used to measure how well Univec manages its routine affairs as well as how well it operates its assets and liabilities.
Univec Inc currently holds 1.65
M in liabilities. Univec Inc has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Univec until it has trouble settling it off, either with new capital or with free cash flow. So, Univec's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Univec Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Univec to invest in growth at high rates of return. When we think about Univec's use of debt, we should always consider it together with cash and equity.
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. The company was founded in 1992 and is based in Baltimore, Maryland. UNIVEC INC operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. Univec Inc [UNVC] is a
Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading.
Management Performance
Univec Inc Management Team
Elected by the shareholders, the Univec's board of directors comprises two types of representatives: Univec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Univec. The board's role is to monitor Univec's management team and ensure that shareholders' interests are well served. Univec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Univec's outside directors are responsible for providing unbiased perspectives on the board's policies.
Univec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Univec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Univec Pink Sheet
Univec financial ratios help investors to determine whether Univec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Univec with respect to the benefits of owning Univec security.